Apogee Therapeutics, Inc. Common Stock (APGE) Live Share Price, Invest From India

Apogee Therapeutics, Inc. Common Stock Stock Performance

as on May 13, 2026 at 6:59 am IST

Day's Low
Day's High
$81.48
Day's Price Range
$85.03
$82.87
1.68%
Downside
2.61%
Upside
52 Week's Low
52 Week's High
$34.34
52-Week Price Range
$95.32
$82.87
58.56%
Downside
15.02%
Upside

Apogee Therapeutics, Inc. Common Stock share price movements today

Previous Close: $84.60
Open: $82.19
Volume: 604.3K
Day's Low - High: $81.48 - $85.03
52 Week Low - High: $34.34 - $95.32

Apogee Therapeutics, Inc. Common Stock Historical Returns

1 Month Return: -1.94 %
3 Month Return: + 22.06 %
1 Year Return: + 113.74 %
3 Year Return: 0 %
5 Year Return: 0 %

Apogee Therapeutics, Inc. Common Stock Stock Fundamentals & Key Indicators

Check Apogee Therapeutics, Inc. Common Stock market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$6.3B

EPS (TTM)

-4.8142

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

-284.2M

Revenue (TTM)

Profit Margin

0.00%

Return On Equity TTM

-31.57%

Apogee Therapeutics, Inc. Common Stock vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Apogee Therapeutics, Inc. Common Stock with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Apogee Therapeutics, Inc. Common Stock	BUY	$6.3B	NA	NA	0.00%
Alnylam Pharmaceuticals Inc	BUY	$39.4B	113.59%	74.13	12.55%
BeiGene, Ltd.	NA	$32.2B	NA	70.46	8.94%
Vertex Pharmaceuticals Inc	BUY	$109.1B	104.61%	25.51	35.51%
Regeneron Pharmaceuticals Inc	BUY	$74.9B	40.55%	17.45	29.65%

Stock Returns calculator for Apogee Therapeutics, Inc. Common Stock Stock including INR - Dollar returns

The Apogee Therapeutics, Inc. Common Stock stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

Apogee Therapeutics, Inc. Common Stock investment value today

Current value as on today

₹2,35,848

Returns

₹1,35,848

(+135.85%)

Returns from Apogee Therapeutics, Inc. Common Stock Stock

₹1,09,373 (+109.37%)

Dollar Impact

₹26,475 (+26.47%)

Analyst Recommendation on Apogee Therapeutics, Inc. Common Stock Stock

Based on 12 analysts

BUY

91.67%

Buy

8.33%

Hold

0.00%

Sell

Based on 12 analysts, 91.67% of analysts recommend a 'BUY' rating for Apogee Therapeutics, Inc. Common Stock. Average target price of $118.31

Apogee Therapeutics, Inc. Common Stock Share Price Target

Get share price movements and forecasts by analysts on Apogee Therapeutics, Inc. Common Stock.

What analysts predicted

29.96%UPSIDE

Target Price

$118.31

Current Price

$82.87

Analyzed by

12 Analysts

Target

$118.31

Apogee Therapeutics, Inc. Common Stock target price $118.31, a slight upside of 29.96% compared to current price of $82.87. According to 12 analysts rating.

Indian Investors' Interest in Apogee Therapeutics, Inc. Common Stock Stock

Search interest for Apogee Therapeutics, Inc. Common Stock Stock has decreased by -86% in the last 30 days, reflecting a downward trend in search activity.

Time period: April 13, 2026 to May 13, 2026

Change:-86% versus previous 30 day period

Apogee Therapeutics, Inc. Common Stock Quarterly Profit & Loss

All numbers in Millions USD

	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Total Revenue	-	-	-	-	-	0	-	-	-	-
Gross Profit	-	-	0	0	0	0	0	0	0	0
Operating Income	-24	-37	-38	-44	-58	-75	-63	-73	-71	-78
EBITDA	-20	-31	-38	-44	-58	-75	-62	-72	-64	-77
Interest Expense	-	-	-	-	-	-	-	-	-	-
Depreciation	-	-	0	0	0	0	0	0	0	0
Income Before Tax	-20	-31	-32	-33	-49	-67	-55	-66	-64	-69
Income Tax Expense	3	0	0	-	-	0	0	0	0	0
Net Income	-20	-31	-32	-33	-49	-67	-55	-66	-65	-69
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	-51706.15%	0.00%	0.00%	0.00%	0.00%

Apogee Therapeutics, Inc. Common Stock Annual Profit & Loss

All numbers in Millions USD

	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	-	-	-	-
Gross Profit	-	-	0	-1
Operating Income	-30	-93	-216	-285
EBITDA	-39	-74	-216	-284
Interest Expense	9	-	-	-
Depreciation	-	-	0	1
Income Before Tax	-39	-83	-182	-255
Income Tax Expense	0	0	0	0
Net Income	-39	-83	-182	-255
Net Profit Margin	0.00%	0.00%	0.00%	0.00%

Apogee Therapeutics, Inc. Common Stock Quarterly Cash Flow

All numbers in Millions USD

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Net Income	-31	-32	-33	-49	-67	-55	-66	-65	-69
Operating Cash Flow	-29	-31	-29	-42	-67	-48	-62	-54	-62
Investing Cash Flow	-273	-51	-148	-146	46	12	78	17	-288
Financing Cash Flow	0	450	0	0	44	0	1	19	374
Change in Cash	-69	367	-178	-188	23	-34	17	-16	23

Apogee Therapeutics, Inc. Common Stock Annual Cash Flow

All numbers in Millions USD

	Dec 2023	Dec 2024	Dec 2025
Net Income	-83	-182	-255
Operating Cash Flow	-74	-171	-227
Investing Cash Flow	-273	-300	-179
Financing Cash Flow	315	495	396
Change in Cash	-33	23	-10

Insights on Apogee Therapeutics, Inc. Common Stock

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Best in 1 Year
In the last 1 year, APGE has outperformed top 5 stocks with highest market-cap in its industry
POSITIVE IMPACT
Price Rise
In the last 3 months, APGE stock has moved up by 24.8%

About Apogee Therapeutics, Inc. Common Stock

Apogee Therapeutics, Inc., a clinical stage biotechnology company, develops novel biologics for the treatment of atopic dermatitis, asthma, eosinophilic esophagitis, chronic obstructive pulmonary disease, and other inflammatory and immunology indications in the United States. The company develops Zumilokibart (APG777), a subcutaneous (SQ) extended half-life monoclonal antibody (mAb) for the treatment of atopic dermatitis, which is in phase 2 clinical trials; and for the treatment of asthma and eosinophilic esophagitis which is in phase 1 clinical trial. It also develops APG279 which is in phase 1 clinical trial for the treatment of atopic dermatitis; APG273 which is in phase 1 clinical trial for the treatment of asthma and chronic obstructive pulmonary disease; and APG808, an SQ extended half-life mAb targeting IL-4Ra for the treatment of Type 2 allergic diseases. Apogee Therapeutics, Inc. was incorporated in 2022 and is headquartered in Waltham, Massachusetts.

Organisation	Apogee Therapeutics, Inc. Common Stock
Headquarters	Building 17, Waltham, MA, United States, 02453
Industry	Biotechnology
CEO	Dr. Michael Thomas Henderson M.D.
E-voting on shares	Click here to vote

Key Management of Apogee Therapeutics, Inc. Common Stock

Name	Title
Dr. Drew Badger Ph.D.	Senior VP and Head of Regulatory Affairs & Toxicology
Ms. Monica Forbes	Senior Vice President of Finance
Dr. Michael Thomas Henderson M.D.	CEO & Director
Ms. Noel Kurdi	Vice President of Investor Relations
Mr. Matthew Batters J.D.	Chief Legal Officer & Corporate Secretary
Ms. Emily Cox	SVP & Head of People
Dr. Rebecca Dabora Ph.D.	Chief Development Officer
Ms. Wendy Aspden-Curran	Senior Vice President of Clinical Operations
Ms. Jane Pritchett V. Henderson	Chief Financial Officer
Dr. Carl Linden Dambkowski M.D.	Chief Medical Officer

FAQs

What is Apogee Therapeutics, Inc. Common Stock share price today?

Apogee Therapeutics, Inc. Common Stock share price today is $82.87 as on May 13, 2026 at 1:29 am IST at the close of the market. Apogee Therapeutics, Inc. Common Stock share today touched a day high of $85.03 and a low of $81.48.

What is the 52 week high and 52 week low for Apogee Therapeutics, Inc. Common Stock share?

Apogee Therapeutics, Inc. Common Stock share touched a 52 week high of $95.32 on April 17, 2026 and a 52 week low of $34.34 on August 8, 2025. Apogee Therapeutics, Inc. Common Stock stock price today i.e. May 13, 2026 at 1:29 am IST is closed at $82.87,which is 13.06% down from its 52 week high and 141.32% up from its 52 week low.

What is Apogee Therapeutics, Inc. Common Stock's market capitalisation today?

Apogee Therapeutics, Inc. Common Stock market capitalisation is $0.01T as on May 13, 2026 at 1:29 am IST.

How to invest in Apogee Therapeutics, Inc. Common Stock Stock (APGE) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Apogee Therapeutics, Inc. Common Stock on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Apogee Therapeutics, Inc. Common Stock Shares that will get you 0.0181 shares as per Apogee Therapeutics, Inc. Common Stock share price of $82.87 per share as on May 13, 2026 at 1:29 am IST.

What is the minimum amount required to buy Apogee Therapeutics, Inc. Common Stock Stock (APGE) from India?

Indian investors can start investing in Apogee Therapeutics, Inc. Common Stock (APGE) shares with as little as ₹95.618 or $1 (as of May 13, 2026 at 6:45 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹956.18 in Apogee Therapeutics, Inc. Common Stock stock (as per the Rupee-Dollar exchange rate as on May 13, 2026 at 6:45 am IST). Based on Apogee Therapeutics, Inc. Common Stock share’s latest price of $82.87 as on May 13, 2026 at 1:29 am IST, you will get 0.1207 shares of Apogee Therapeutics, Inc. Common Stock. Learn more about fractional shares .